Essentra plc (FLRAF)
Oxford, GB
Essentra plc operates as a global provider of essential industrial components and specialized solutions. Its Components division focuses on the manufacturing and distribution of a wide array of items, including injection-molded plastic, vinyl dip-molded, and metal parts. These serve critical applications across sectors such as equipment manufacturing, automotive, fabrication, electronics, and construction. The product portfolio ranges from protective and finishing elements like caps, plugs, wire and cable management solutions, flange protection, knobs, handles, and grips, to specialized PCB and electronics hardware, tools, and precision instruments. The Packaging division delivers packaging materials such as cartons, leaflets, self-adhesive labels, and printed foils, frequently used in blister pack applications. This segment also supplies comprehensive packaging and authentication solutions, primarily targeting the health and personal care industries. The Filter division offers filtration products and associated packaging, particularly for the roll-your-own tobacco market. Additionally, it provides analytical laboratory services and develops specialized e-cigarette and heat-not-burn solutions for emerging product categories. The company, originally known as Filtrona plc, formally changed its name to Essentra plc in June 2013. Essentra plc was incorporated in 2005 and maintains its headquarters in Milton Keynes, United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -0.82% | -19.33% | -2.42% | -4.72% | -11.68% | -46.22% | -71.86% | -89.69% | -70.49% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-0.2% Q4'25: -0.3% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%-80.1% Q4'25: +195.4% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+9.6% ★ Q4'25: +2.2% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%+7.0% Q4'25: +7.4% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%+5.9% ★ Q4'25: +7.4% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%-0.5% ★ Q4'25: +0.7% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.54× Q4'25: 1.24× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 1 EPS Ana. |
Dec 2027 7 Rev. Ana. 1 EPS Ana. |
Dec 2028 4 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.10B
est: 1.67B (-34.1%)
|
998.50M
est: 1.38B (-27.8%)
|
1.03B
est: 1.38B (-25.8%)
|
1.03B
est: 1.32B (-22.0%)
|
974.10M
est: 1.29B (-24.3%)
|
896.50M
est: 1.23B (-27.4%)
|
301.70M
est: 1.31B (-77.0%)
|
337.90M
est: 416.97M (-19.0%)
|
316.30M
est: 414.13M (-23.6%)
|
302.40M
est: 301.86M (+0.2%)
|
301.95M
est: 300.58M (+0.5%)
|
310.74M
302.30M – 313.81M
+3.4% YoY
|
326.15M
318.79M – 333.31M
+5.0% YoY
|
341.62M
333.15M – 347.11M
+4.7% YoY
|
| EBITDA |
164.60M
est: 208.81M (-21.2%)
|
18.90M
est: 173.16M (-89.1%)
|
119.90M
est: 173.39M (-30.8%)
|
126.00M
est: 164.77M (-23.5%)
|
151.60M
est: 161.26M (-6.0%)
|
92.50M
est: 154.64M (-40.2%)
|
42.40M
est: 164.24M (-74.2%)
|
27.70M
est: 52.22M (-47.0%)
|
48.20M
est: 51.87M (-7.1%)
|
44.80M
est: 66.10M (-32.2%)
|
49.89M
est: 65.82M (-24.2%)
|
68.05M
66.20M – 68.72M
+3.4% YoY
|
71.42M
69.81M – 72.99M
+5.0% YoY
|
74.81M
72.95M – 76.01M
+4.7% YoY
|
| EBIT |
84.40M
est: 67.68M (+24.7%)
|
-48.80M
est: 56.12M (-187.0%)
|
4.90M
est: 56.20M (-91.3%)
|
48.20M
est: 53.40M (-9.7%)
|
81.00M
est: 52.27M (+55.0%)
|
30.10M
est: 50.12M (-39.9%)
|
18.90M
est: 53.23M (-64.5%)
|
700.0K
est: 16.93M (-95.9%)
|
17.00M
est: 16.81M (+1.1%)
|
15.40M
est: 29.96M (-48.6%)
|
21.00M
est: 29.84M (-29.6%)
|
30.85M
30.01M – 31.15M
+3.4% YoY
|
32.38M
31.65M – 33.09M
+5.0% YoY
|
33.91M
33.07M – 34.46M
+4.7% YoY
|
| Net Income |
67.90M
est: 114.32M (-40.6%)
|
-40.30M
est: 89.97M (-144.8%)
|
114.30M
est: 57.80M (+97.7%)
|
24.30M
est: 55.51M (-56.2%)
|
38.40M
est: 55.29M (-30.5%)
|
-3.30M
est: 33.21M (-109.9%)
|
26.90M
est: 44.81M (-40.0%)
|
-188.00M
est: 16.14M (-1,265.0%)
|
5.40M
est: 28.36M (-81.0%)
|
10.60M
est: 24.32M (-56.4%)
|
2.10M
est: 17.58M (-88.1%)
|
18.82M
18.21M – 19.21M
+7.0% YoY
|
22.12M
21.40M – 22.58M
+17.5% YoY
|
25.48M
24.66M – 26.02M
+15.2% YoY
|
| SGA |
156.30M
est: 66.15M (+136.3%)
|
200.0K
est: 54.86M (-99.6%)
|
-5.20M
est: 54.93M (-109.5%)
|
168.00M
est: 52.20M (+221.9%)
|
142.90M
est: 51.09M (+179.7%)
|
700.0K
est: 48.99M (-98.6%)
|
400.0K
est: 52.03M (-99.2%)
|
66.00M
est: 16.54M (+298.9%)
|
300.0K
est: 16.43M (-98.2%)
|
—
est: 11.93M (-100.0%)
|
—
est: 11.88M (-100.0%)
|
12.28M
11.95M – 12.40M
+3.4% YoY
|
12.89M
12.60M – 13.17M
+5.0% YoY
|
13.50M
13.17M – 13.72M
+4.7% YoY
|
| EPS |
0.26
est: 0.39 (-34.1%)
|
-0.15
est: 0.31 (-148.3%)
|
0.44
est: 0.20 (+120.5%)
|
0.09
est: 0.19 (-51.6%)
|
0.15
est: 0.19 (-21.4%)
|
-0.01
est: 0.11 (-110.6%)
|
-0.02
est: 0.15 (-113.5%)
|
-0.12
est: 0.06 (-315.4%)
|
0.02
est: 0.10 (-78.4%)
|
0.04
est: 0.08 (-56.1%)
|
0.01
est: 0.06 (-87.9%)
|
0.07
0.06 – 0.07
+7.0% YoY
|
0.08
0.07 – 0.08
+17.5% YoY
|
0.09
0.09 – 0.09
+15.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Scott Morgan Taylor Fawcett | Chief Executive Officer, MD of Components Division & Executive Director | 1M | male |
| Rowan Clare Baker | CFO, Interim Company Secretary & Director | 790.4K | female |
| Christopher Brooks | Managing Director of Americas | — | male |
| Emma Reid | Head of Governance | — | female |
| Jennifer Spence | ESG Director | — | — |
| Lucy Yank | Group Communications Director | — | female |
| Richard Sederman | Managing Director of APAC | — | male |
| Sam Edwards | Chief Digital Information Officer | — | male |
| Shaun Laubscher | Chief People Officer | — | male |
| Aamir Mohiuddin | Director of Investor Relations | — | — |
| Tim George | Deputy Company Secretary | — | male |
| Chris Butler | Site Operations Director of Essentra Kidlington | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FLRAF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
